Quality of Life of Gynecologic Cancer Survivors
N/A
N/A
Female
Endometrial Cancer, Ovarian Cancer
Trial Information
Quality of Life of Gynecologic Cancer Survivors
OBJECTIVES:
- Describe the significant quality of life (QOL) concerns and long term survivorship
issues of women diagnosed and treated for early stage ovarian and endometrial cancer
five or more years ago.
- Identify mechanisms which contribute to a gynecologic cancer survivorship model through
comparison and prediction of high versus low QOL associated with long term adjustment
and survivorship. Examine social support, coping efforts, self-efficacy, meaning
associated with survivorship, performance status, and age at diagnosis as potential
predictors.
- Identify and compare factors that predict high versus low QOL for women with early
stage endometrial cancer completing participation in GOG-99 clinical trial. Conduct
exploratory analysis examining long term QOL concerns of survivors randomized to
surgery arm with or without radiotherapy.
OUTLINE: Patients complete one telephone interview with a professional female interviewer.
The interview lasts approximately 60 minutes and is audiotaped.
PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early
stage ovarian cancer survivors will be accrued for this study within 2 years.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed early stage ovarian and endometrial cancer survivors treated
and diagnosed five or more years ago
- Patients completing treatment in GOG-95 or GOG-99 protocols at least 5 years ago with
no recurrence of disease
- Patients with secondary malignancy or under treatment for other medical conditions
are eligible
PATIENT CHARACTERISTICS:
Age:
- Not specified
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- Must be capable of completing telephone interview in English
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- See Disease Characteristics
Chemotherapy:
- See Disease Characteristics
Endocrine therapy:
- See Disease Characteristics
Radiotherapy:
- See Disease Characteristics
Surgery:
- See Disease Characteristics
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Lari B. Wenzel, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
Chao Family Comprehensive Cancer Center
Authority:
United States: Federal Government
Study ID:
CDR0000066938
NCT ID:
NCT00003795
Start Date:
April 1999
Completion Date:
Related Keywords:
- Endometrial Cancer
- Ovarian Cancer
- stage I ovarian epithelial cancer
- stage II ovarian epithelial cancer
- stage I endometrial carcinoma
- stage II endometrial carcinoma
- Endometrial Neoplasms
- Ovarian Neoplasms
- Adenoma
Name | Location |
|---|---|
| Fred Hutchinson Cancer Research Center | Seattle, Washington 98109 |
| Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
| University of Texas - MD Anderson Cancer Center | Houston, Texas 77030-4009 |
| Jonsson Comprehensive Cancer Center, UCLA | Los Angeles, California 90095-1781 |
| Chao Family Comprehensive Cancer Center | Orange, California 92868 |
| University of Colorado Cancer Center | Denver, Colorado 80262 |
| Walter Reed Army Medical Center | Washington, District of Columbia 20307-5000 |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa, Florida 33612 |
| Rush-Presbyterian-St. Luke's Medical Center | Chicago, Illinois 60612 |
| University of Chicago Cancer Research Center | Chicago, Illinois 60637 |
| Indiana University Cancer Center | Indianapolis, Indiana 46202-5265 |
| Albert B. Chandler Medical Center, University of Kentucky | Lexington, Kentucky 40536-0084 |
| University of Massachusetts Memorial Medical Center | Worcester, Massachusetts 01655 |
| University of Mississippi Medical Center | Jackson, Mississippi 39216-4505 |
| Washington University School of Medicine | Saint Louis, Missouri 63110 |
| Cooper Hospital/University Medical Center | Camden, New Jersey 08103 |
| Cancer Center of Albany Medical Center | Albany, New York 12208 |
| State University of New York Health Science Center at Brooklyn | Brooklyn, New York 11203 |
| University of Rochester Cancer Center | Rochester, New York 14642 |
| State University of New York Health Sciences Center - Stony Brook | Stony Brook, New York 11790-7775 |
| Lineberger Comprehensive Cancer Center, UNC | Chapel Hill, North Carolina 27599-7295 |
| Duke Comprehensive Cancer Center | Durham, North Carolina 27710 |
| Barrett Cancer Center, The University Hospital | Cincinnati, Ohio 45219 |
| Ireland Cancer Center | Cleveland, Ohio 44106-5065 |
| Arthur G. James Cancer Hospital - Ohio State University | Columbus, Ohio 43210 |
| University of Oklahoma College of Medicine | Oklahoma City, Oklahoma 73190 |
| Abington Memorial Hospital | Abington, Pennsylvania 19001 |
| Milton S. Hershey Medical Center | Hershey, Pennsylvania 17033 |
| Kimmel Cancer Center of Thomas Jefferson University - Philadelphia | Philadelphia, Pennsylvania 19107 |
| University of Pennsylvania Cancer Center | Philadelphia, Pennsylvania 19104 |
| Fox Chase Cancer Center | Philadelphia, Pennsylvania 19111 |
| Medical University of South Carolina | Charleston, South Carolina 29425-0721 |
| Simmons Cancer Center - Dallas | Dallas, Texas 75235-9154 |
| Tacoma General Hospital | Tacoma, Washington 98405 |
| New England Medical Center Hospital | Boston, Massachusetts 02111 |
| University of Alabama at Birmingham Comprehensive Cancer Center | Birmingham, Alabama 35294-3300 |
| Community Hospital of Los Gatos | Los Gatos, California 95032 |
| Holden Comprehensive Cancer Center at The University of Iowa | Iowa City, Iowa 52242-1009 |
| Comprehensive Cancer Center at Wake Forest University | Winston-Salem, North Carolina 27157-1082 |
| Brookview Research, Inc. | Nashville, Tennessee 37203 |
| CCOP - Montana Cancer Consortium | Billings, Montana 59101 |
| Cleveland Clinic Taussig Cancer Center | Cleveland, Ohio 44195 |
| Schneider Children's Hospital at North Shore | Manhasset, New York 11030 |
